Amelioration of Laminin- 2-Deficient Congenital Muscular Dystrophy by Somatic Gene Transfer of Miniagrin

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.0502137102
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

Current Understanding and Treatment of Cardiac and Skeletal Muscle Pathology in Laminin-Α2 Chain-Deficient Congenital Muscular Dystrophy

The Application of Clinical Genetics
Genetics
2019English

Congenital Muscular Dystrophy

The Internet Journal of Radiology
2010English

Angiotensin II Type 1 Receptor Antagonists Alleviate Muscle Pathology in the Mouse Model for Laminin-Α2-Deficient Congenital Muscular Dystrophy (MDC1A)

Skeletal Muscle
OrthopedicsSports MedicineCell BiologyMolecular Biology
2012English

Moderately Progressive Ullrich Congenital Muscular Dystrophy

Jornal de Pediatria
Child HealthPediatricsPerinatology
2011English

Congenital Muscular Dystrophy and .ALPHA.-dystroglycanopathy

Clinical Neurology
Neurology
2008English

Congenital Muscular Dystrophy With Cerebellar Involvement

2020English

Congenital Muscular Dystrophy: From Muscle to Brain

Italian Journal of Pediatrics
Child HealthPediatricsPerinatology
2016English

Dystrophic Phenotype of Canine X-Linked Muscular Dystrophy Is Mitigated by Adenovirus-Mediated Utrophin Gene Transfer

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2003English

Neuronal Nitric Oxide Synthase and Dystrophin-Deficient Muscular Dystrophy.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy